Health Condition 1: null- Patients belonging to ASA grade I& II, Age group between 40 and 65 years, Body Mass Index 25 kg/m2±10% posted for abdominal hysterectomy
Conditions
Interventions
Intervention1: Group A will receive powdered Tab. Tapentadol 75 mg: orally with a sip of water one hour before the scheduled surgery.
Control Intervention1: Group B will receive powdered Tab. Tramadol
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: Patients belonging to ASA grade I& II, Body Mass Index 25 kg/mt2±10% posted for abdominal hysterectomy lasting less than 120 min
Exclusion criteria
Exclusion criteria: Patients with hypo or hyperthyroidism Axillary temperature above 37°C or below 35â??. Compromised cardio-respiratory functions History of allergy Pregnancy Neuromuscular pathology Cases requiring blood or blood products administration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug failure (shivering grade 2 or 3)Timepoint: Throughout intraoperative period and first 2 hours of postoperative period | — |
Secondary
| Measure | Time frame |
|---|---|
| Axillary temperatureTimepoint: recorded at 5 min intervals for first 60 min, and thereafter at 15 min intervals for a time duration of 120 min;Haemodynamic parametersTimepoint: recorded at 5 min intervals for first 60 min, and thereafter at 15 min intervals for a time duration of 120 min;occurrence and severity of shiveringTimepoint: Throughout intraoperative period and first 2 hours of postoperative period;SedationTimepoint: recorded at 5 min intervals for first 60 min, and thereafter at 15 min intervals for a time duration of 120 min;Side effectsTimepoint: Throughout the period of observation | — |
Countries
India
Contacts
Public ContactGhanshyam Yadav
Institute of Medical Sciences, Banaras Hindu University
Outcome results
None listed